Sarah Kishinevsky, PhD is a dynamic and accomplished professional in the fields of economics, mathematics, and neuroscience. With a passion for bridging the gap between academia and entrepreneurship, Kishinevsky is the Director and Head of BioVenture eLab at Weill Cornell Medicine, where she leads a team focused on accelerating innovation and bringing ideas to market. Prior to this role, she founded the Bench to Bedside Initiative and served as a doctoral candidate at both Memorial Sloan Kettering Cancer Center and Weill Cornell Graduate School of Medical Sciences. Kishinevsky’s extensive background also includes experience as a technician at Columbia University Vagelos College of Physicians and Surgeons and as an investment banking analyst at Bear, Stearns & Co., Inc. Her impressive educational background includes a BA in Economics-Mathematics from Columbia College (NY) and a PhD in Neuroscience from Weill Cornell Medical College.